We then correlated frequencies of CD8+ TILs abundance and ITGAE and CD69 gene expression with clinical outcomes by analyzing the independent data set mentioned previously for n = 153 GBM patients for whom follow-up was available. This evidence concerns the gene CD69 and glioblastoma.